SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Doug Bean who wrote (888)2/9/1999 11:50:00 PM
From: tommysdad  Read Replies (1) of 1837
 
You really don't want them saying anything about Cenestin. The FDA has already "ruled against" the drug, when DRMD was going after generic Premarin status. Anything the company says at this point is only going to get FDA mad, and you really don't want that. Even if ruled "approvable", FDA can still come back and make DRMD jump through all kinds of hoops to get marketing clearance ("we don't like the chemical name you're using here" "we want you to change the font size on the package insert in this section"). No news is good news right now . . .
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext